Myocardial infarction is the major cause of death in the world. Over the last two decades,
coronary reperfusion therapy has become established for the management of acute …

Objective To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and
angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in …

Reperfusion does not only salvage ischaemic myocardium but can also cause additional
cell death which is called lethal reperfusion injury. The time of reperfusion is often …

Myocardial ischemia–reperfusion (MI/R) represents a clinically relevant problem associated
with thrombolysis, angioplasty, and coronary bypass surgery. MI/R injury is known to occur …

Purpose To review (1) the mechanisms of coronary microvascular reperfusion injury,
particularly in the relationships between microvascular endothelium dysfunction …

Myocardial apoptosis is primarily triggered during reperfusion. Various mechanisms are
involved, including oxidative stress which activates the translocation of nuclear factor-kappa …

Myocardial ischemia may occur as a result of pathophysiological and therapeutical
applications such as atherosclerosis, thromboembolism, percutaneous transluminal …

Arrhythmias are frequent complication in patients with acute myocardial infarction (MI). The
importance of accelerated idioventricular rhythm (AIVR), ventricular fibrillation or tachycardia …

Introduction: Angiotensin (Ang) A was first identified in human plasma and it differs from Ang
II in Ala1 instead of Asp1. Here, we hypothesized that the actions of this peptide might …

Abstract Angiotensin II receptor 1 (AT1) antagonists are beneficial in focal
ischemia/reperfusion (I/R). However, in cases of global I/R, such as cardiac arrest (CA), AT1 …